Production begins at uniQure MA plant to support gene therapy pipeline
Uniqure has begun manufacturing runs at a new 50,000 sq. ft. single-use gene therapy plant in Massachusetts.
Uniqure has begun manufacturing runs at a new 50,000 sq. ft. single-use gene therapy plant in Massachusetts.
Researchers in Fukushima will use Pluristem’s placenta-based PLX-R18 cell therapy to investigate a treatment for Acute Radiation Syndrome (ARS).
Making the newly approved asthma drug Nucala (mepolizumab) involves facilities on both sides of the Atlantic according to GSK, which says it has no plan to outsource production.